BioSpace News Archive

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Australian biotech company Ferronova announced it has secured a further A$11 million to progress the company’s nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors.

January 22, 2023
·
4 min read
Drug Development

Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc. announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF, a multinational, randomized, double-blind, placebo-controlled Phase 2a clinical trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

January 22, 2023
·
11 min read
Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress

Mallinckrodt plc announced the presentation of results from a retrospective analysis of three North American-centric, Phase III, randomized, placebo-controlled studies comparing the incidence of hepatorenal syndrome reversal with baseline acute-on-chronic liver failure grade in adults with rapid reduction in kidney function2 treated with TERLIVAZ® plus albumin versus those treated with placebo plus albumin.

January 22, 2023
·
10 min read